Can regulatory T cells improve outcomes of sensitised patients after HLA-Ab incompatible renal transplantation: study protocol for the Phase IIa GAMECHANgER-1 trial by C Dudreuilh, P Jarvis, N Beadle, I Pilecka, O Shaw, L Gardner, C Scottà, N Mamode, DS Game, A Sanchez-Fueyo, G Lombardi, A Learoyd, A Douiri, A Dorling

Get full text